Research programme: deuterium-containing therapeutics - Concert Pharmaceuticals

Drug Profile

Research programme: deuterium-containing therapeutics - Concert Pharmaceuticals

Alternative Names: C-10068; C-20081; C-21246; C-21359; CTP-221; D-apremilast; D-boceprevir; D-cilostazol; D-darunavir; D-iloprost; D-lenalidomide; D-linezolid; D-ranolazine

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Concert Pharmaceuticals
  • Developer Concert Pharmaceuticals; GlaxoSmithKline
  • Class Neuroprotectants; Organic deuterium compounds; Oxazolidinones; Small molecules; Sodium compounds; Sulfonamides; Synthetic prostaglandins
  • Mechanism of Action Angiogenesis inhibitors; Epoprostenol agonists; GABA A receptor modulators; Hepatitis C protease inhibitors; Hepatitis C virus NS3 protein inhibitors; HIV protease inhibitors; Immunomodulators; Interleukin 1 beta stimulants; Interleukin 10 stimulants; Partial fatty acid oxidation inhibitors; Platelet aggregation inhibitors; Protein 30S ribosomal subunit inhibitors; Pyruvate dehydrogenase stimulants; Sigma-1 receptor agonists; Tumour necrosis factor inhibitors; Type 3 cyclic nucleotide phosphodiesterase inhibitors; Type 4 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Cancer; Cardiovascular disorders; Epilepsy; Hepatitis C; HIV infections; Inflammation; Kidney disorders; Methicillin-resistant Staphylococcus aureus infections; Neuropathic pain; Pulmonary arterial hypertension

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in USA
  • 04 Nov 2017 No recent reports of development identified for preclinical development in HIV-infections in USA
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Inflammation in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top